BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31608054)

  • 1. CD27
    von Borstel A; Land J; Abdulahad WH; Rutgers A; Stegeman CA; Diepstra A; Heeringa P; Sanders JS
    Front Immunol; 2019; 10():2221. PubMed ID: 31608054
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
    Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
    Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of IgD-CD27
    Wang C; Li ZY; Gong Y; You R; Ming-Hui ; Zhao ; Chen M
    Arthritis Res Ther; 2022 May; 24(1):109. PubMed ID: 35568913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
    Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
    Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis.
    Land J; Abdulahad WH; Arends S; Sanders JF; Stegeman CA; Heeringa P; Rutgers A
    PLoS One; 2017; 12(8):e0182549. PubMed ID: 28771641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis.
    Elmér E; Smargianaki S; Pettersson Å; Skattum L; Ohlsson S; Hellmark T; Johansson ÅCM
    J Immunol Res; 2020; 2020():8209737. PubMed ID: 33313327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
    Chang DY; Li ZY; Chen M; Zhao MH
    Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD27
    Wilbrink R; Spoorenberg A; Arends S; van der Geest KSM; Brouwer E; Bootsma H; Kroese FGM; Verstappen GM
    Front Immunol; 2021; 12():686273. PubMed ID: 34168654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    von Borstel A; Abdulahad WH; Dekkema G; Rutgers A; Stegeman CA; Veldman J; Heeringa P; Sanders JS
    PLoS One; 2020; 15(7):e0235743. PubMed ID: 32645052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis.
    Land J; Abdulahad WH; Sanders JS; Stegeman CA; Heeringa P; Rutgers A
    Arthritis Res Ther; 2016 Apr; 18():84. PubMed ID: 27044386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The avidity of PR3-ANCA in patients with granulomatosis with polyangiitis during follow-up.
    Kemna MJ; Schlumberger W; van Paassen P; Dähnrich C; Damoiseaux JG; Cohen Tervaert JW
    Clin Exp Immunol; 2016 Aug; 185(2):141-7. PubMed ID: 27009928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate.
    Salmela A; Rasmussen N; Tervaert JWC; Jayne DRW; Ekstrand A;
    Rheumatology (Oxford); 2017 Jun; 56(6):965-972. PubMed ID: 28339745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease Activity and Tendency to Relapse in ANCA-Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies.
    Smargianaki S; Elmér E; Lilliebladh S; Ohlsson S; Pettersson Å; Hellmark T; Johansson ÅC
    J Immunol Res; 2024; 2024():6648265. PubMed ID: 38213873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Yonsei Med J; 2018 May; 59(3):397-405. PubMed ID: 29611402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.
    Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.